FRC
FRC Logo
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • FAQ
  • How to use FRC

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Commodities

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Research
Get Access
Sign In
West Pharmaceutical Services, Inc. Stock AnalysisComprehensive stock analysis for West Pharmaceutical Services, Inc. (WST) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisWST
WST
West Pharmaceutical Services, Inc.
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
WST
Home🔹Stocks🔹West Pharmaceutical Services, Inc.

West Pharmaceutical Services, Inc.

🇺🇸WST•NYSE

West Pharmaceutical Services, Inc.

🇺🇸WST•NYSE
Market cap
$24.37B
Sentiment

Your view on WST

Mkt Cap
$24.37B
Sentiment
Your view
WST
West Pharmaceutical Services, Inc.
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
WST
Company Overview

Overview

What the company does, where it operates, and who runs it.

About West Pharmaceutical Services, Inc.

Industry
Medical - Instruments & Supplies
Sector
Healthcare
CEO
Eric M. Green
Headquarters
530 Herman O. West Drive, Exton, PA, US
Industry
Medical - Instruments & Supplies
Sector
Healthcare
CEO
Eric M. Green
Headquarters
530 Herman O. West Drive, Exton, PA, US
Description

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products.

The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components.

It also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices, as well as a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support.

This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.

It serves pharmaceutical, diagnostic, and medical device companies. The company distributes its products through its sales force and distribution network, as well as contract sales agents and regional distributors. West Pharmaceutical Services, Inc. was incorporated in 1923 and is headquartered in Exton, Pennsylvania.

FRC Research

Media

Infographics, videos, and posts covering the company.

Financial Data

Stock Data

Price chart, volume, and trading data.

Fair Value

What FRC thinks it is worth vs. the current price.

FRC's fair value estimate for West Pharmaceutical Services, Inc., and the rating behind it. WST last traded at $346.23, 44.2× trailing earnings — the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

Valuation, profitability, liquidity and leverage ratios for West Pharmaceutical Services, Inc.. Starting points for West Pharmaceutical Services, Inc.: P/E 44.2, EPS $7.98, beta 1.14 — an Medical - Instruments & Supplies name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

Dividend history, yield and payout sustainability for West Pharmaceutical Services, Inc.. West Pharmaceutical Services, Inc. paid $0.88 per share over the last year — a 0.3% yield at the current $346.23 price. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

Reported vs. expected earnings history for West Pharmaceutical Services, Inc.. Trailing twelve-month EPS for West Pharmaceutical Services, Inc. stands at $7.98. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Financial Statements

Income statement, balance sheet, and cash flow statements.

Income statement, balance sheet and cash flow history for West Pharmaceutical Services, Inc.. West Pharmaceutical Services, Inc. has reported as a listed company since 1980. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

West Pharmaceutical Services, Inc. valued side by side against its closest peers. West Pharmaceutical Services, Inc. is measured against Medical - Instruments & Supplies peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.

Ownership & News

Institutional Ownership

Premium

Which funds and firms own the stock.

Which institutions hold West Pharmaceutical Services, Inc., and how their positions are changing. At a $24.37B market value, institutional positions materially move West Pharmaceutical Services, Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.

Insider Trading

Premium

Recent buying and selling by company executives.

Buying and selling by West Pharmaceutical Services, Inc. executives and directors. Shares of West Pharmaceutical Services, Inc. have traded between $187.43 and $348.90 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.

Senate Trading

Premium

U.S. Senator disclosures filed under the STOCK Act.

U.S. Senate disclosures naming West Pharmaceutical Services, Inc.. West Pharmaceutical Services, Inc. is a $24.37B Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.

House Trading

Premium

U.S. Representative disclosures filed under the STOCK Act.

U.S. House of Representatives disclosures naming West Pharmaceutical Services, Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.

News

Latest headlines and market coverage.

Latest headlines and company announcements for West Pharmaceutical Services, Inc.. Coverage tracks West Pharmaceutical Services, Inc. within Medical - Instruments & Supplies (Healthcare). Press releases and market coverage, newest first.

Peer companies

  • COO — The Cooper Companies, Inc.
  • DGX — Quest Diagnostics Incorporated
  • ILMN — Illumina, Inc.
  • INCY — Incyte Corporation
  • LH — Labcorp Holdings Inc.
  • MEDP — Medpace Holdings, Inc.
  • STE — STERIS plc

More Medical - Instruments & Supplies companies

  • STAA — STAAR Surgical Company
  • STSS — Sharps Technology, Inc.
  • STVN — Stevanato Group S.p.A.
  • STXS — Stereotaxis, Inc.
  • SUVPF — Sartorius AG
  • SVSO — SheerVision, Inc.
  • TCGGY — Tecan Group AG
  • TCHBF — Tecan Group AG
  • TDVXF — Tobii Dynavox AB (publ)
  • TFX — Teleflex Incorporated
  • TGLVY — Top Glove Corporation Bhd.
  • TRJ.AX — Trajan Group Holdings Limited

ETFs holding West Pharmaceutical Services, Inc.

  • KMID — Virtus KAR Mid-Cap ETF (5.12%)
  • ACTS — FIS Tactical Equity ETF (2.81%)
  • BASG — Brown Advisory Sustainable Growth ETF (2.74%)
  • TMFM — Motley Fool Mid-Cap Growth ETF (2.71%)
  • MDEV — First Trust Indxx Medical Devices ETF (2.60%)
  • ARWG — Archer Growth ETF (2.55%)
  • SMCO — Hilton Small-MidCap Opportunity ETF (2.53%)
  • KONG — Formidable Fortress ETF (2.46%)

News

Latest Market News